Condition
Schizophrenia and Related Disorders
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 56 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
56 shownSPARK Healthy SleepNCT07119268 · 2025-10-24
RECRUITINGBilateral Prefrontal and Insular TMS for Depression in SchizophreniaNCT07060066 · 2025-10-23
RECRUITINGTele-group Cognitive Behavioural Family Intervention for Individuals With Schizophrenia and Their Families (Definitive tgCBFI)NCT07121166 · 2025-09-01
RECRUITINGIntensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment FailureNCT05603104 · 2025-04-27
RECRUITINGAlternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation TreatmentNCT02916810 · 2025-02-01
RECRUITINGThe Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.NCT05958875 · 2024-08-01
RECRUITINGMitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial DysfunctionNCT06191965 · 2024-06-01
RECRUITINGSocial Isolation and Aging in SchizophreniaNCT07419321 · 2024-01-09
RECRUITINGExercise Therapy in Mental Disorders-studyNCT06313918 · 2023-09-27
RECRUITINGAvatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing VoicesNCT05982158 · 2023-08-08
RECRUITINGrTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia PatientsNCT05671185 · 2022-12-01
RECRUITING"Extended" (Alternate Day) Antipsychotic DosingNCT04478838 · 2022-06-06
RECRUITINGSemantic and Syntactic Computerized Analysis of Free SpeechNCT03525054 · 2018-05-18
RECRUITINGDeveloping a Virtual Reality-assisted Intervention for Emotion Regulation Difficulties in PsychosisNCT07623928 · 2027-09-01
NOT_YET_RECRUITINGDigital Implementation Support to Achieve Uptake and Integration of Task-Shared Care for Schizophrenia in Primary Care in IndiaNCT06043778 · 2026-10-01
NOT_YET_RECRUITINGClay Therapy in Schizophrenia PatientsNCT07378150 · 2025-12-01
COMPLETEDA Trial of Extended Reality Activities to Enhance Leisure Participation Among Inpatients With Persistent Mental Health ConditionsNCT06964477 · 2025-07-01
NOT_YET_RECRUITINGKetogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic ProfilingNCT06748950 · 2025-07-01
NOT_YET_RECRUITINGKetosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderSNCT06426134 · 2024-12-01
COMPLETEDAccelerated rTMS for Psychomotor SlowingNCT06134661 · 2023-09-22
TERMINATEDEmbedded Narrative in Interactive Game Design for Improving Medication Adherence of SchizophreniaNCT06175559 · 2023-09-01
COMPLETEDEEG Outcomes From Cognitive Behavioural Therapy for PsychosisNCT05703698 · 2023-02-01
COMPLETEDMechanistic Clinical Trial of Individualized tDCS for Hallucinations in SchizophreniaNCT04248010 · 2022-12-01
WITHDRAWNAn Extension Protocol for Patients Who Previously Completed the TMS Pilot StudyNCT05526833 · 2022-09-12
TERMINATED"InMotion" - Physical Training With Creative Movement as an Intervention for Adults With SchizophreniaNCT05673941 · 2022-09-01
UNKNOWNIndividualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal HallucinationsNCT05319080 · 2022-08-01
TERMINATEDIncreasing Medication Check Participation Through Applying CT-rNCT06231407 · 2022-03-17
COMPLETEDCommunity Reinforcement Approach and Family Training for Substance Use in Early Psychosis InterventionNCT05300633 · 2022-02-08
COMPLETEDReal-life Assessment of Abilify Maintena + Rexult in SchizophreniaNCT05169268 · 2022-02-01
COMPLETEDCultural Adaptation of Group CBT Psychosis Manual and Establishing Its Efficacy in PakistanNCT07005388 · 2021-10-04
COMPLETEDDynamics of Risk Perception and Risk Behavior in Alcohol Use Disorder and SchizophreniaNCT04985786 · 2021-07-10
UNKNOWNComparative Effectiveness of CET vs. SST in SMI (Serious Mental Illness)NCT04321759 · 2021-06-01
UNKNOWNMetacognitive Training as a Serious GameNCT04631939 · 2021-06-01
UNKNOWNtDCS and Executive Function Training for SchizophreniaNCT05389345 · 2021-05-01
WITHDRAWNFace Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".NCT04902066 · 2021-04-09
COMPLETEDLinguistic Predictors of Outcomes in PsychosisNCT05601050 · 2021-03-04
COMPLETEDClozapine Use Pattern in the Province of SevilleNCT05083377 · 2020-09-08
COMPLETEDEfficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic DisordersNCT04366401 · 2020-06-25
COMPLETEDDEcision-making Capacity: Intervention Development & Evaluation in Schizophrenia-spectrum DisorderNCT04309435 · 2020-02-22
UNKNOWNSubstance Misuse To Psychosis for StimulantsNCT03485417 · 2019-06-01
COMPLETEDOvercoming Psychomotor Slowing in Psychosis (OCoPS-P)NCT03921450 · 2019-03-25
COMPLETEDThe Police-Mental Health Linkage SystemNCT03740139 · 2019-02-06
COMPLETEDEvaluation of Excellence in Italy's Residence for Execution of Security MeasureNCT06018298 · 2018-07-01
COMPLETEDImproving Cognition Via Exercise in SchizophreniaNCT03270098 · 2018-04-26
COMPLETEDThe Norwegian Prednisolone in Early Psychosis StudyNCT03340909 · 2018-02-02
TERMINATEDTranscranial Direct Current Stimulation (tDCS) to Improve Gesture ControlNCT03463902 · 2018-01-29
TERMINATEDTranscranial Magnetic Stimulation to Improve Gesture ControlNCT03483909 · 2018-01-29
COMPLETEDThinking Skills at Work: Cognitive Remediation Therapy for Patients With Serious Mental IllnessNCT03483701 · 2017-04-01
COMPLETEDRole of an E-cigarette on Smoking Displacement in Smokers With SchizophreniaNCT03075202 · 2017-03-03
COMPLETEDExercise and Overnight Motor Sequence TaskNCT03800368 · 2016-12-21
COMPLETEDTranscranial Magnetic Stimulation (TMS) for Motor Symptoms in Psychiatric DisordersNCT03275766 · 2016-06-01
COMPLETEDComparison of E-health vs. In-person Multi-Family Group (MFG)NCT02032680 · 2015-08-19
COMPLETEDA Register Study of Effects Following Local Variation in Rates of Involuntary CareNCT04655287 · 2015-01-01
COMPLETEDEmployment Outcomes After Vocational TrainingNCT03152032 · 2014-08-01
COMPLETEDA Trial of "Opening Doors to Recovery" for Persons With Serious Mental IllnessesNCT04612777 · 2014-06-15
COMPLETEDStudy on Psychoeducation Enhancing Results of Adherence in SchizophreniaNCT01433094 · 2012-09-01
COMPLETEDCommon interventions
Active rTMS stimulationDEVICE2ClozapineDRUG2paliperidoneDRUG2PlaceboDEVICE2PlaceboDRUG2Repetitive Transcranial Magnetic Stimulation (rTMS)DEVICE2Sham rTMS stimulationDEVICE2Treatment as usual (TAU)OTHER2(R)-3-hydroxybutyl (R)-3-hydroxybutyrate)DIETARY_SUPPLEMENT11 Hz rTMSDEVICE1Aerobic ExerciseBEHAVIORAL1AripiprazoleDRUG1ARIPiprazole Injection [Abilify]DRUG1Avatar therapyBEHAVIORAL1BrexpiprazoleDRUG1BupropionDRUG1Case ManagementBEHAVIORAL1Clay therapyOTHER1Cognitive Behavioral Therapy for increasing non-risk behaviorsBEHAVIORAL1Cognitive behavioral therapy for psychosisBEHAVIORAL1Cognitive Behavioral Therapy for reducing risk behaviorsBEHAVIORAL1Cognitive behavioural therapy (CBT)BEHAVIORAL1Cognitive Behavioural Therapy for PsychosisBEHAVIORAL1Cognitive Behavioural Virtual Reality Therapy.OTHER1Cognitive Enhancement TherapyBEHAVIORAL1
Leading sponsors
University of Bern
5
Columbia University
4
The University of Hong Kong
3
Centre for Addiction and Mental Health
2
Dr. Inge Winter
2
Haukeland University Hospital
2
Icahn School of Medicine at Mount Sinai
2
The University of Texas Health Science Center, Houston
2
University of Toronto
2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
1
Beth Israel Deaconess Medical Center
1
Chia-Hui Hung
1
Christina Andreou
1
Edinburgh Napier University
1
Fraser Health
1
Trial status mix
COMPLETED27
RECRUITING13
TERMINATED5
UNKNOWN5
NOT_YET_RECRUITING4
WITHDRAWN2
Phase mix
NA41
PHASE24
PHASE33
PHASE42
PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.